XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)Jun 1, 2024 | (Q1)Mar 2, 2024 | (FY)Nov 25, 2023 | (Q4)Nov 25, 2023 | (Q3)Aug 26, 2023 | (Q2)May 27, 2023 | (Q1)Feb 25, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -78.37%4.05M | -24.80%6.37M | -110.53%-404K | -0.51%5.82M | -1,474.60%-7.74M | 730.44%18.72M | -9.12%8.48M | 214.54%3.84M | 149.53%5.85M | -80.36%563K |
Net income from continuing operations | -205.74%-9.7M | 178.13%3.2M | -73.87%-4.51M | -446.87%-7.2M | -182.56%-1.19M | -104.85%-3.17M | -181.60%-4.1M | -133.97%-2.59M | -95.59%2.08M | -74.07%1.45M |
Operating gains losses | 40.00%7K | ---- | ---- | ---- | ---- | 100.01%5K | ---- | ---- | ---- | ---- |
Depreciation and amortization | -2.20%9.92M | -12.66%2.31M | -10.45%2.32M | 2.26%2.63M | 13.85%2.66M | -10.33%10.14M | 2.41%2.64M | -2.77%2.59M | 6.60%2.57M | -35.98%2.34M |
Deferred tax | -393.86%-2.44M | -9.78%323K | -1,735.80%-1.33M | -299.23%-518K | -798.48%-922K | 135.53%831K | -30.75%358K | -91.38%81K | 106.65%260K | 13.79%132K |
Other non cash items | 28.95%7.28M | 30.60%1.39M | -23.61%1.32M | 113.51%4.27M | -64.55%302K | 68.68%5.64M | -44.72%1.06M | -96.78%1.73M | 103.76%2M | 10.65%852K |
Change In working capital | -4,737.78%-6.53M | -127.49%-853K | -11.88%1.78M | 207.41%1.13M | -104.23%-8.59M | 99.43%-135K | 348.04%3.1M | 118.92%2.02M | 75.62%-1.05M | 41.97%-4.21M |
-Change in receivables | -86.47%555K | -112.91%-207K | 202.96%521K | -87.14%447K | 56.17%-206K | 29.44%4.1M | -48.49%1.6M | -126.83%-506K | 25.00%3.48M | 89.80%-470K |
-Change in inventory | -83.12%3.02M | -63.35%1.13M | -115.89%-338K | -64.49%2.2M | -99.61%25K | 287.38%17.87M | -25.82%3.07M | 79.65%2.13M | 155.46%6.2M | 275.95%6.47M |
-Change in payables and accrued expense | 21.14%-7.25M | 27.67%-1.88M | -26.44%1.57M | 13.67%-3.56M | 26.59%-3.37M | -125.58%-9.19M | 50.91%-2.6M | 158.11%2.13M | -158.14%-4.12M | -109.48%-4.6M |
-Change in other current assets | -27.51%14.83M | -57.44%3.01M | 30.26%4.33M | 15.46%6.28M | -73.84%1.21M | -22.75%20.45M | -7.32%7.07M | 161.91%3.32M | -46.83%5.44M | -37.10%4.62M |
-Change in other current liabilities | -2.18%-20.64M | 5.05%-4.94M | -5.03%-4.97M | 9.14%-4.5M | -17.34%-6.22M | 12.00%-20.2M | 4.13%-5.21M | 10.29%-4.74M | 3.45%-4.96M | 25.45%-5.3M |
-Change in other working capital | 122.42%2.95M | 343.68%2.04M | 315.56%679K | 103.62%257K | 99.51%-24K | 20.58%-13.18M | 84.50%-838K | 94.82%-315K | 12.36%-7.1M | -264.15%-4.92M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -78.37%4.05M | -24.80%6.37M | -110.53%-404K | -0.51%5.82M | -1,474.60%-7.74M | 730.44%18.72M | -9.12%8.48M | 214.54%3.84M | 149.53%5.85M | -80.36%563K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 50.64%-8.77M | -117.68%-3.14M | 81.12%-1.56M | 58.43%-1.72M | 39.91%-2.35M | -126.98%-17.76M | -101.89%-1.44M | -406.74%-8.28M | 59.77%-4.14M | -35.56%-3.9M |
Net PPE purchase and sale | 69.33%-5.21M | 78.95%-491K | 85.70%-1.04M | 60.46%-1.61M | 37.86%-2.08M | -29.98%-16.99M | 42.13%-2.33M | -302.06%-7.25M | 60.21%-4.06M | -38.34%-3.34M |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | -4,208.33%-2.59M | ---- | ---- | ---- | ---- | ---60K | ---- | ---- | ---- | ---- |
Net other investing changes | -36.13%-972K | -106.63%-63K | 48.78%-526K | -52.70%-113K | 52.04%-270K | -100.85%-714K | -98.89%950K | -15.39%-1.03M | -1.37%-74K | -21.08%-563K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 50.64%-8.77M | -28.54%-3.14M | 81.12%-1.56M | 45.19%-1.72M | 39.91%-2.35M | -126.98%-17.76M | 70.31%-2.44M | -583.59%-8.28M | -104.17%-3.14M | -35.56%-3.9M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 20.63%-8.12M | -15.21%-1.99M | -9.38%-2.36M | 31.22%-2.06M | 48.80%-1.72M | 71.24%-10.23M | 72.60%-1.72M | 30.62%-2.15M | 87.39%-2.99M | -35.60%-3.36M |
Net issuance payments of debt | 8.99%-253K | 38.57%-43K | 19.72%-57K | -16.18%-79K | -7.25%-74K | 59.36%-278K | -6.06%-70K | 12.35%-71K | 33.98%-68K | 84.10%-69K |
Net common stock issuance | 72.81%-1.05M | -155.84%-197K | -6.69%-542K | 73.76%-396K | 104.88%86K | 73.75%-3.86M | 98.39%-77K | 65.16%-508K | 80.64%-1.51M | -162.50%-1.76M |
Cash dividends paid | -11.23%-6.65M | -10.72%-1.75M | -11.56%-1.76M | -11.98%-1.58M | -10.70%-1.57M | 70.33%-5.98M | -10.36%-1.58M | -0.64%-1.57M | 91.07%-1.41M | -3.42%-1.42M |
Net other financing activities | -47.71%-161K | --0 | --0 | --0 | -47.71%-161K | -473.68%-109K | --0 | --0 | --0 | ---109K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 20.63%-8.12M | -15.21%-1.99M | -9.38%-2.36M | 31.22%-2.06M | 48.80%-1.72M | 71.24%-10.23M | 72.60%-1.72M | 30.62%-2.15M | 87.39%-2.99M | -35.60%-3.36M |
Net cash flow | ||||||||||
Beginning cash position | -14.96%52.41M | -20.17%38.33M | -21.90%42.65M | -26.02%40.61M | -14.96%52.41M | 79.28%61.63M | -28.20%48.01M | -23.75%54.6M | 72.18%54.89M | 79.28%61.63M |
Current changes in cash | -38.52%-12.84M | -71.02%1.25M | 34.48%-4.32M | 840.94%2.05M | -76.12%-11.81M | -133.93%-9.27M | 183.09%4.31M | -39.16%-6.6M | -100.69%-276K | -168.81%-6.7M |
Effect of exchange rate changes | -143.75%-21K | -131.76%-27K | 0.00%5K | 38.46%-8K | 131.03%9K | 182.76%48K | 246.55%85K | --5K | ---13K | ---29K |
End cash Position | -24.53%39.55M | -24.53%39.55M | -20.17%38.33M | -21.90%42.65M | -26.02%40.61M | -14.96%52.41M | -14.96%52.41M | -28.20%48.01M | -23.75%54.6M | 72.18%54.89M |
Free cash flow | -194.01%-1.16M | 4.24%5.88M | 57.82%-1.44M | 135.89%4.21M | -253.31%-9.82M | 105.09%1.24M | 6.57%5.64M | 57.18%-3.42M | 108.11%1.79M | -728.51%-2.78M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |